title: Fatal, gold-induced pneumonitis.
abstract: We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.
authors.affiliation: Servicio de Neumologia, Hospital General Universitario, Alicante, Spain.
authors.forename: M Jose
authors.initials: MJ
authors.lastname: Soler
authors.forename: Encarnacion
authors.initials: E
authors.lastname: Barroso
authors.forename: F Ignacio
authors.initials: FI
authors.lastname: Aranda
authors.forename: Sergio
authors.initials: S
authors.lastname: Alonso
authors.forename: Santiago
authors.initials: S
authors.lastname: Romero
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D017809:Fatal Outcome; D005260:Female; D006052:Gold Sodium Thiomalate / Q000009:adverse effects*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*
chemical_list: D018501:Antirheumatic Agents; D006052:Gold Sodium Thiomalate